STOCK TITAN

HIVE (HIVE) director sells 175,000 shares, keeps unvested RSUs vesting through 2027

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

HIVE Digital Technologies director Dave Perrill reported a net sale of shares. On June 19, 2026 he sold 175,000 common shares in open-market transactions, leaving no common shares directly owned after the sale. Earlier, on May 7, 2026, he exercised previously granted restricted share units (RSUs) that converted into common shares on a one-for-one basis under the company’s Restricted Share Unit Plan. Footnotes show RSUs that vested and were settled into common stock on May 7, 2026, as well as additional RSU awards that remain unvested and are scheduled to vest in installments through March 16, 2027.

Positive

  • None.

Negative

  • None.

Insights

Director fully liquidates current shares but still holds future RSUs.

Director Dave Perrill sold 175,000 HIVE Digital Technologies common shares in open-market trades on June 19, 2026, reducing his directly held common share balance to zero. This followed the May 7, 2026 conversion of RSUs into common shares.

The filing also details RSU grants that vested and converted on May 7, 2026, plus additional RSU awards that will vest in stages on August 5, 2026, November 5, 2026, July 8, 2026, October 31, 2026 and March 16, 2027. These represent future equity that will convert into common shares when vesting conditions are met.

Because the sale size is not compared to the company’s total shares outstanding, the broader impact is hard to gauge from this filing alone. The key takeaway is a complete sale of current direct common holdings, offset by a pipeline of unvested RSUs scheduled to vest over the next several disclosed dates.

Insider Perrill Dave
Role null
Sold 175,000 shs ($821K)
Type Security Shares Price Value
Sale Common Shares 175,000 $4.69 $821K
Exercise Restricted stock units 100,000 $0.00 --
Exercise Restricted stock units 12,500 $0.00 --
Exercise Common Shares 100,000 $0.00 --
Exercise Common Shares 12,500 $0.00 --
Holdings After Transaction: Common Shares — 0 shares (Direct, null); Restricted stock units — 337,500 shares (Direct, null)
Footnotes (1)
  1. Reflects restricted share units ("RSUs") issued pursuant to the Issuer's Restricted Share Unit Plan (the "RSU Plan") that, upon vesting and settlement converted into shares of Issuer common stock on a one-for-one basis. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from C$6.589 to C$6.660, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The weighted average price reported above was converted from the Canadian weighted average price of C$6.639 to USD$4.57, using an exchange rate of USD$1.00 = C$0.705, as reported by the Bank of Canada on June 19, 2026. Reflects 100,000 RSUs that were awarded on April 17, 2025 and vested on April 17, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan. Reflects 12,500 RSUs that were awarded on November 5, 2024 and vested on May 5, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan. Reflects additional RSU awards that have not vested and converted that were previously reported. The underlying shares and vesting schedules are as follows: (i) 25,000 vest in two equal installments of 12,500 on each of August 5, 2026 and November 5, 2026; (ii) 100,000 will vest on July 8, 2026; (iii) 100,000 will vest on October 31, 2026 and (iv) 100,000 will vest on March 16, 2027.
Common shares sold 175,000 shares Open-market sale on June 19, 2026 by director Dave Perrill
Canadian sale price range C$6.589–C$6.660 per share Price range for June 19, 2026 open-market sales
Weighted average Canadian price C$6.639 per share Weighted average price for June 19, 2026 sales
RSUs converted on May 7, 2026 100,000 RSUs Awarded April 17, 2025; vested April 17, 2026 and converted May 7, 2026
Additional RSUs converted 12,500 RSUs Awarded November 5, 2024; vested May 5, 2026 and converted May 7, 2026
Future RSU vesting (installments) 12,500 RSUs each date Two installments vesting August 5, 2026 and November 5, 2026
Future single-date RSU vesting 100,000 RSUs each date Vesting on July 8, 2026; October 31, 2026; March 16, 2027
Restricted Share Unit Plan financial
"issued pursuant to the Issuer's Restricted Share Unit Plan (the "RSU Plan")"
A restricted share unit plan is a company program that promises employees or executives actual company shares or cash tied to the company’s stock, delivered later once conditions like continued employment or performance targets are met. Think of it as a delayed paycheck paid in stock that becomes fully owned only after certain milestones. Investors care because these awards can change the number of shares outstanding, affect reported costs, and align employee actions with shareholder value.
restricted share units ("RSUs") financial
"Reflects restricted share units ("RSUs") issued pursuant to the Issuer's"
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
vested financial
"were awarded on April 17, 2025 and vested on April 17, 2026."
converted into common shares financial
"vested and settlement converted into shares of Issuer common stock"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Perrill Dave

(Last)(First)(Middle)
7900 CALLAGHAN ROAD
SUITE 128

(Street)
SAN ANTONIO TEXAS 78229

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HIVE Digital Technologies Ltd. [ HIVE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
[HIVE]
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares05/07/2026M100,000A(1)162,500D
Common Shares05/07/2026M12,500A(1)175,000D
Common Shares06/19/2026S175,000D$4.69(2)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted stock units(1)05/07/2026M100,000 (3) (3)Common Stock100,000$0337,500D
Restricted stock units(1)05/07/2026M12,500 (4) (4)Common Stock12,500$0325,000(5)D
Explanation of Responses:
1. Reflects restricted share units ("RSUs") issued pursuant to the Issuer's Restricted Share Unit Plan (the "RSU Plan") that, upon vesting and settlement converted into shares of Issuer common stock on a one-for-one basis.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from C$6.589 to C$6.660, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The weighted average price reported above was converted from the Canadian weighted average price of C$6.639 to USD$4.57, using an exchange rate of USD$1.00 = C$0.705, as reported by the Bank of Canada on June 19, 2026.
3. Reflects 100,000 RSUs that were awarded on April 17, 2025 and vested on April 17, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan.
4. Reflects 12,500 RSUs that were awarded on November 5, 2024 and vested on May 5, 2026. These RSUs were settled and converted into common shares of the Issuer on May 7, 2026, in accordance with the Issuer's RSU Plan.
5. Reflects additional RSU awards that have not vested and converted that were previously reported. The underlying shares and vesting schedules are as follows: (i) 25,000 vest in two equal installments of 12,500 on each of August 5, 2026 and November 5, 2026; (ii) 100,000 will vest on July 8, 2026; (iii) 100,000 will vest on October 31, 2026 and (iv) 100,000 will vest on March 16, 2027.
/s/ Dave Perrill06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did HIVE (HIVE) director Dave Perrill report in this Form 4?

Dave Perrill reported selling 175,000 HIVE common shares in open-market transactions on June 19, 2026. He also disclosed earlier RSU conversions on May 7, 2026, and additional unvested RSU awards scheduled to vest on several dates through March 16, 2027.

How many HIVE (HIVE) shares did Dave Perrill sell and at what price range?

He sold 175,000 HIVE common shares. Footnotes state these were executed in multiple trades at prices ranging from C$6.589 to C$6.660 per share, with a Canadian weighted average price of C$6.639 across the transactions reported.

Did Dave Perrill retain any directly owned HIVE (HIVE) common shares after the sale?

After selling 175,000 common shares, the Form 4 shows Dave Perrill with zero directly held HIVE common shares. However, he still holds unvested RSU awards that may convert into additional common shares as they vest according to their disclosed schedules.

What RSUs for HIVE (HIVE) vested and converted on May 7, 2026?

The filing notes 100,000 RSUs awarded on April 17, 2025 vested on April 17, 2026 and converted into common shares on May 7, 2026. Another 12,500 RSUs awarded November 5, 2024 vested May 5, 2026 and also converted on May 7, 2026.

What future RSU vesting schedule is disclosed for HIVE (HIVE) director Dave Perrill?

Remaining RSU awards will vest as follows: 25,000 RSUs in two 12,500 installments on August 5 and November 5, 2026; 100,000 RSUs on July 8, 2026; another 100,000 on October 31, 2026; and 100,000 more on March 16, 2027.

How were HIVE (HIVE) share sale prices converted between Canadian dollars and U.S. dollars?

The weighted average sale price was calculated in Canadian dollars, then converted to U.S. dollars using an exchange rate of USD$1.00 = C$0.705, as referenced from the Bank of Canada rate on June 19, 2026 in the footnote.